QRxPharma Ltd - Strategic SWOT Analysis Review

QRxPharma Ltd - Strategic SWOT Analysis Review

  • Products Id :- GDPH138339SA
  • |
  • Pages: 21
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

QRxPharma Ltd-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.


QRxPharma Ltd (QRxPharma) develops and commercializes treatments for pain management and abuse prevention products. The company's product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR (Q8003), an immediate release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV (Q8012), an intravenous formulation for moderate to severe hospital-based pain; and Moxduo CR (Q8011), a controlled release oral tablet being developed in Phase II clinical trial for the treatment of chronic pain. The company's abuse deterrent technology called Stealth Beadlets has been developed for controlled release Moxduo formulation. It has operations in the US and Australia. QRxPharma is headquartered in North Sydney, New South Wales, Australia.

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

QRxPharma Ltd-Key Facts 5

QRxPharma Ltd-Key Employees 6

QRxPharma Ltd-Major Products and Services 7

QRxPharma Ltd-History 8

QRxPharma Ltd-Locations And Subsidiaries 9

Head Office 9

Other Locations & Subsidiaries 9

Joint Venture 9

Section 2-Company Analysis 10

Company Overview 10

QRxPharma Ltd-Business Description 11

QRxPharma Ltd-Corporate Strategy 12

QRxPharma Ltd-SWOT Analysis 13

SWOT Analysis-Overview 13

QRxPharma Ltd-Strengths 13

QRxPharma Ltd-Weaknesses 14

QRxPharma Ltd-Opportunities 15

QRxPharma Ltd-Threats 16

QRxPharma Ltd-Key Competitors 17

Section 3-Company's Lifesciences Financial Deals and Alliances 18

QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18

QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 19

QRxPharma Ltd, Recent Deals Summary 20

Section 4-Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21

List of Figures

QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18

QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 19

List of Tables

QRxPharma Ltd, Key Facts 5

QRxPharma Ltd, Key Employees 6

QRxPharma Ltd, Major Products and Services 7

QRxPharma Ltd, History 8

QRxPharma Ltd, Subsidiaries 9

QRxPharma Ltd, Joint Venture 9

QRxPharma Ltd, Key Competitors 17

QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18

QRxPharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 19

QRxPharma Ltd, Recent Deals Summary 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

UniQuest Pty Ltd

Spinifex Pharmaceuticals Pty Ltd

Molecular Pharmacology Limited

QRxPharma Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license
Single User License
USD 125 INR 8625
Site License
USD 250 INR 17250
Corporate User License
USD 375 INR 25875



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com